Quintiles Transnational Corp. names Senior Vice President, Global Marketing and Chief Marketing Officer and Senior Vice President, Communications and Patient Recruitment.
Quintiles Appoints New Executives
RESEARCH TRIANGLE PARK, N.C., June 19 /PRNewswire/ -- Quintiles Transnational Corp. today named Millie Tan to Senior Vice President, Global Marketing and Chief Marketing Officer and David Coman to the position of Senior Vice President, Communications and Patient Recruitment.
"Both Dave and Millie bring a wealth of experience and impressive records of success in marketing and communication," said Mike Mortimer, Chief Administrative Officer. "I am excited to have them join our senior management team to play key roles in our efforts to strengthen our presence in the marketplace."
Millie joins Quintiles from Monster Worldwide, the global online employment solutions provider, monster.com . Most recently, she was Chief Marketing Officer of its European business, prior to which, she led core marketing in the US. Previously, Millie held increasingly senior positions in consumer marketing with Polaroid and Gillette, including overseas assignments in Hong Kong and Tokyo. She earned her bachelor's degree from Skidmore College in Saratoga Springs, NY, and her master's degree at Columbia University, followed by an MBA at Dartmouth College.
David joins Quintiles from Dendrite International where he was the VP of Global Marketing and led both Marketing and Corporate Communications. Previously, David held executive leadership positions in high-growth telecommunications companies where he initiated groundbreaking
direct-to-consumer strategies. He began his career with Young & Rubicam, a
market-leading global advertising agency. He earned his bachelor's degree at Michigan State and his MBA from Northwestern University.
About Quintiles
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the biotechnology and healthcare industries. With more than 21,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company's Web site at www.quintiles.com .
SOURCE Quintiles Transnational Corp.
-0- 06/19/2008
/CONTACT: Mari Mansfield, Media Relations of Quintiles Transnational Corp., +1-919-998-2639, +1-919-259-3298 (mobile), [email protected]/
/Web site: http://www.quintiles.com
http://www.qtrn.com /
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.